Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib vs Diclofenac in Rheumatoid Arthritis (EDGE-II)
NCT00092742Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Feb 2003
- Primary completion
- Dec 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of etoricoxib in rheumatoid arthritis (RA) (2 arms), sponsored by Organon & Co. Primary endpoint: Discontinuations due to clinical and laboratory gastrointestinal adverse experiences at 12 months. Started Feb 2003; status: completed.
02
Drugs
etoricoxib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00092742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092742.